Paintings conservators have used the Australian Synchrotron to investigate the deterioration of zinc oxide pigments, which can cause cracks and lumps in some oil paintings.

Applications have now closed for the 2014 Australian Synchrotron Stephen Wilkins Thesis Medal. The award will be announced at the Australian Synchrotron User Meeting in November 2014.

Join us on 20-21 November at User Meeting 2014, and on 19 November for New User Symposium 2014.

West Australian researchers met recently with beamline scientists to learn more about using the Australian Synchrotron to further their research goals.

Users who submitted applications for January-May 2015 (round 2015/1) will be notified from mid-December 2014.

Australia’s growing ability to develop and trial new drugs here rather than seeing them realised overseas is both a clear indicator and a consequence of excellence, productivity and reliability at all stages from synchrotron research experiments to industrial manufacturing processes.

An international printing technology and components company is using the Australian Synchrotron to support its quality control, product design and fabrication activities.

Fresh insights into milk digestion could lead to new milk products for dieters and premature babies.

A newly developed therapeutic antibody recruits the body’s own immune system to kill cancer cells, offering a new approach to treating acute myeloid leukaemia.

The Australian Synchrotron is helping to accelerate research into a protein with a split personality that is linked to type 1 diabetes.